In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D 2 receptor agonists 1

By Ahlenius S.   Ericson E.   Florvall L.   Jimenez P.   Hillegaart V.   Wijkstrom A.  

European Journal of Pharmacology, Vol. 394, Iss. 2, 2000-04 ,pp. : 247-253

Elsevier

Access to resources Recommend Favorite

Partial Dopamine Agonists and the Treatment of Psychosis

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine receptor agonists linked with impulse control disorders

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 141-147

Bentham Science Publishers

Access to resources Recommend Favorite

Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 156-165

Bentham Science Publishers

Access to resources Recommend Favorite